Reply to the letter to the editor: genetic influence on visual outcomes of polypoidal choroidal vasculopathy

被引:0
|
作者
Hata, Masayuki [1 ,2 ]
Tsujikawa, Akitaka [1 ,2 ]
Yoshimura, Nagahisa [1 ,2 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan
[2] Kagawa Univ, Fac Med, Dept Ophthalmol, 1750-1 Ikenobe,Miki Cho, Kagawa 7610793, Japan
关键词
Optical Coherence Tomography; Ranibizumab; Fluorescein Angiography; Visual Outcome; Indocyanine Green;
D O I
10.1007/s00417-015-3163-3
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:1021 / 1022
页数:2
相关论文
共 50 条
  • [1] Reply to the letter to the editor: genetic influence on visual outcomes of polypoidal choroidal vasculopathy
    Masayuki Hata
    Akitaka Tsujikawa
    Nagahisa Yoshimura
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2016, 254 : 1021 - 1022
  • [2] Genetic influence on visual outcomes of polypoidal choroidal vasculopathy
    Colin S. Tan
    Wei Kiong Ngo
    Louis W. Lim
    Tock Han Lim
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2016, 254 : 1019 - 1020
  • [3] Photodynamic Therapy for Polypoidal Choroidal Vasculopathy REPLY
    Sato, Taku
    Kishi, Shoji
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2010, 150 (05) : 755 - 755
  • [4] Reply to the letter to the editor: Two-year results of treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy
    Morimoto, Masahiro
    Matsumoto, Hidetaka
    Mimura, Kensuke
    Akiyama, Hideo
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 256 (01) : 225 - 226
  • [5] Treatment Outcomes in Eyes with Polypoidal Choroidal Vasculopathy with Poor Baseline Visual Acuity
    Kim, Jae Hui
    Kim, Jong Woo
    Lee, Tae Gon
    Lew, Young Ju
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2015, 31 (04) : 241 - 247
  • [6] Clinical outcomes in Caucasian patients with polypoidal choroidal vasculopathy
    Agorogiannis, Eleftherios I.
    Pearce, Ian A.
    Yadav, Sohraab
    Parry, David G.
    Beare, Nicholas A. V.
    EYE, 2018, 32 (11) : 1731 - 1739
  • [7] Choroidal thickness profile and clinical outcomes in eyes with polypoidal choroidal vasculopathy
    Young Ho Kim
    Boram Lee
    Edward Kang
    Jaeryung Oh
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2021, 259 : 1711 - 1721
  • [8] Choroidal thickness profile and clinical outcomes in eyes with polypoidal choroidal vasculopathy
    Kim, Young Ho
    Lee, Boram
    Kang, Edward
    Oh, Jaeryung
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2021, 259 (07) : 1711 - 1721
  • [9] Visual Outcomes and Prognostic Factors of Large Submacular Hemorrhages Secondary to Polypoidal Choroidal Vasculopathy
    Matsuo, Yu
    Haruta, Masatoshi
    Ishibashi, Yumi
    Ishibashi, Koki
    Furushima, Kei
    Kato, Nobuhiro
    Murotani, Kenta
    Yoshida, Shigeo
    CLINICAL OPHTHALMOLOGY, 2021, 15 : 3557 - 3562
  • [10] ONE-YEAR OUTCOMES OF INTRAVITREAL BEVACIZUMAB (AVASTIN) THERAPY FOR POLYPOIDAL CHOROIDAL VASCULOPATHY
    Cheng, Cheng-Kuo
    Peng, Chi-Hsien
    Chang, Chun-Kai
    Hu, Chao-Chien
    Chen, Lee-Jen
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (05): : 846 - 856